基于适配体的蛋白质组学识别透析依赖AKI患者死亡相关血清生物标志物
该研究对VA/NIH急性肾衰竭试验网络研究中100例患者第1天和107例患者第8天的血清样本,用SOMAscan平台检测1305种蛋白质。比较8天内死亡与存活>8天患者,发现54种蛋白变化,其中FGF23、tPA、MMP-8和suPAR较高水平与更高死亡率相关,多变量调整后仍持续。第8天FGF23、tPA和IL-6上三分位水平与死亡率增加相关。
要点
- FGF23、tPA、MMP-8和suPAR较高水平与透析依赖AKI患者死亡率增加独立相关。
- 第8天FGF23、tPA和IL-6上三分位水平与死亡率增加相关。
- 适配体蛋白质组学可识别低丰度血清蛋白,有助于区分高死亡风险AKI-D患者。
核心结论
- 适配体蛋白质组学可识别与透析依赖AKI死亡风险相关的低丰度血清蛋白。
研究设计与样本
- 研究分析VA/NIH急性肾衰竭试验网络研究中100例患者第1天和107例患者第8天的血清样本。
- 采用慢解离率修饰适配体扫描蛋白质组学平台检测每份样本中的1305种蛋白质。
- 按基线生物标志物测量值将患者分为三分位,用Cox回归分析生物标志物血清水平与死亡率的关系。
主要发现
- 比较8天内死亡与存活>8天患者,检测到54种蛋白血清水平变化,其中33种升高、21种降低。
- 在33种升高的蛋白中,FGF23、tPA、MMP-8和suPAR较高血清水平按三分位分层与更高死亡率相关。
- 调整年龄、性别、心血管SOFA评分、充血性心力衰竭和糖尿病后,上述每种蛋白与死亡率的关联持续存在。
- 第8天FGF23、tPA和IL-6上三分位水平与死亡率增加相关,但FGF23在多变量调整后勉强失去显著性。
临床怎么用
- 可考虑用FGF23、tPA、MMP-8和suPAR等血清标志物辅助识别透析依赖AKI高死亡风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Currently, no effective therapies exist to reduce the high mortality associated with dialysis-dependent acute kidney injury (AKI-D). Serum biomarkers may be useful in understanding the pathophysiological processes involved with AKI and the severity of injury, and point to novel therapeutic targets. METHODS: Study day 1 serum samples from 100 patients and day 8 samples from 107 patients enrolled in the Veteran's Affairs/National Institutes of Health Acute Renal Failure Trial Network study were analyzed by the slow off-rate modified aptamers scan proteomic platform to profile 1305 proteins in each sample. Patients in each cohort were classified into tertiles based on baseline biomarker measurements. Cox regression analyses were performed to examine the relationships between serum levels of each biomarker and mortality. RESULTS: Changes in the serum levels of 54 proteins, 33 of which increased and 21 of which decreased, were detected when comparing samples of patients who died in the first 8 days versus patients who survived >8 days. Among the 33 proteins that increased, higher serum levels of fibroblast growth factor-23 (FGF23), tissue plasminogen activator (tPA), neutrophil collagenase (matrix metalloproteinase-8), and soluble urokinase plasminogen activator receptor, when stratified by tertiles, were associated with higher mortality. The association with mortality persisted for each of these proteins after adjusting for other potential risk factors, including age, sex, cardiovascular sequential organ failure assessment score, congestive heart failure, and presence of diabetes. Upper tertile levels of FGF23, tPA, and interleukin-6 on day 8 were associated with increased mortality; however, FGF23 barely lost significance after multivariable adjustment. CONCLUSIONS: Our results underscore an emerging proteomics tool capable of identifying low-abundance serum proteins important not only in the pathogenesis of AKI-D, but which is also helpful in discriminating AKI-D patients with high mortality.
引用
- Yu LR, Sun J, Daniels JR, et al. Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients. Kidney Int Rep. 2018. PMID: 30197987. doi:10.1016/j.ekir.2018.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。